Table 2 Demographic characteristics of 576 patients who treated with statin derivations.

From: Evaluation of LDL goal achievement in statin consumption, south east of Iran

Framingham risk variable

Risk category

Extreme risk (n = 9)

Very high risk (n = 337)

High risk (n = 55)

Moderate risk (n = 175)

P value

Age

73.56 ± 10.10

66.53 ± 9.89

64.55 ± 6.86

57.41 ± 7.70*+#

< 0.001

Female

9 (100%)

237 (70.3)

9 (16.4)

119 (68)

< 0.001

FBS

133.11 ± 52.14

127.57 ± 46.25

102.63 ± 12.25+

99.73 ± 11.71+

< 0.001

Cr

1 ± 0.2

1.06 ± 0.51

0.95 ± 0.2

0.89 ± 0.18+

< 0.001

GFR

55.02 ± 29.84

67.35 ± 29.75

85.4 ± 19.07*+

91.44 ± 21.27*+

< 0.001

BMI

27.91 ± 4.24

28.93 ± 5.49

28.86 ± 4.21

30.55 ± 4.39+

< 0.001

WC

97 ± 10.9

100.15 ± 10.96

102.69 ± 9.07

103.3 ± 9.07+

0.003

Smoker

1 (11.1)

8 (2.4)

5 (9.1)

1 (0.6)

0.004

SBP

143.89 ± 20.12

134.27 ± 16.10

133.36 ± 14.56

128.83 ± 14.89+

< 0.001

DBP

80 ± 10

78.87 ± 10.33

80.91 ± 10

79.48 ± 8.33

0.501

  1. Chol total cholesterol, TG triglyceride, FBS fasting blood sugar, BMI body mass index, WC waist circumference, SBP systolic blood pressure, DBP diastolic blood pressure.
  2. *Exterme risk versus other groups.
  3. +Very high versus other groups.
  4. #High versus other groups.
Back to article page